It is important to use a different model of patient engagement that is more suited to the needs and unique values of patients in Asia. Key…
In Conversation
Our clients are always looking for new ways to tell the story about their company, their products and how to support patients
We, as Turkish Cargo, carry out our operations at top level by holding the "CEIV Pharma" certificate issued by IATA CEIV (Center of Excellence for Independent…
In Turkey NCDs account for 89 percent of all deaths with nearly one in five occurring in people under the age of 70-years
The innovation power that private enterprises have has to be used in the public healthcare system.
Turkey is an attractive investment destination due to its dynamic economy, young population and comprehensive national health system which covers most people living in Turkey, not…
I like the fact that Vision 2030 does not only focus on the localisation of products, but on the country’s human capital itself and the transfer…
The Kingdom of Saudi Arabia is a part of almost every discussion around Biogen’s future plans globally
Italy and its researchers have created a good environment for science. However, the country needs to better focus on translating the knowledge and the quality of…
Our advantage is due to unparalleled investment in biosimilar R&D and production; no other company in Turkey has invested as much as Arven
A lot of work is going on to increase funding for paediatric cancer and many centres – mine included – are not necessarily waiting around for…
We have the potential to make significant contributions to Saudi’s Vision 2030 because of our extensive portfolio and capabilities in artificial intelligence (AI) and IT solutions…
